PharmaBoardroom

Robert Matsuk – President, Glenmark North America

Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US - including a manufacturing facility…

Cell & Gene Therapy Manufacturing: Critical Challenges,…

Deloitte's Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in…

Biocon’s Recipe for Success in the Competitive US Generics…

Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of generic medicines now available on…

Why Technology Is Key To Surviving COVID-19

Sophia Ononye-Onyia outlines the key failings in the USA’s response to the coronavirus outbreak and why greater numbers of inter-industry…

Hot Topics in Belgian Pharma

In 2020 PharmaBoardroom sat down with several key stakeholders in Belgian pharma to discuss company strategy, the Belgian healthcare landscape at…

Salim El Guermai – CEO & Head Pharmacist, Galenica,…

Salim El Guermai, CEO & head pharmacist of Galenica, a leading generics company in Morocco, presents the original mission of the company to…

Americo Garcia – Managing Director, Latin America, Apotex

Americo Garcia oversees Latin American operations for Canadian generics player Apotex. He outlines the firm’s impressive growth in the region in…

KV Kumar – President & CEO, Indian American…

KV Kumar, head of the Indian American International Chamber of Commerce, gives an account of the bilateral trade relations between India and the US…

Abhijit Zutshi – Commercial Head Global Generics & SVP…

Abhijit Zutshi, commercial head global generics & SVP marketing at Indian firm Biocon highlights the challenges inherent in the US generics…

Amr El-Neklawy – General Manager Middle East, North &…

Emcure, a fully-integrated Indian pharmaceutical company with a global presence, has invested in Dubai as an operational hub for the Middle East,…

Romania: Europe’s Most Challenging Market for Generics?

While the dismal regulatory environment in Romania has negatively affected the innovators with the uncertain and lengthy regulatory approval timelines…

5 Cell & Gene Companies to Watch in South Korea

South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Tagged with GEN